Ed Edelson


New drugs, techniques promising, but more data needed

New York-Some antifibrosis drugs and techniques on the horizon appear promising, but more data, especially from controlled human trials, are needed, Paul J. Lama, MD, told those attending the Glaucoma 2006 meeting here.

SLT appears effective for steroid-induced glaucoma

New York-The idea of using selective laser trabeculoplasty (SLT) for steroid-induced glaucoma originated with a patient's stubborn resistance to surgery, according to Janet P. Serle, MD.

Imaging devices may help with glaucoma detection

New York-Some imaging devices may help predict which patients will develop glaucoma, but "they will not supplant clinical assessment of the optic disc by a trained observer," said Christopher A. Girkin, MD, MSPH, to attendees of the Glaucoma 2006 meeting here.

XFS puts individuals at great risk for blindness

October 01, 2006

New York-A patient with exfoliation syndrome (XFS) may have the worst type of open-angle glaucoma, according to Robert Ritch, MD, who opened a session on XFS at the Glaucoma 2006 meeting.

Device provides option for selected glaucoma patients

September 01, 2006

New York-The Ex-PRESS glaucoma implant (Optonol) is a device that may be coming into its own, at least for some selected patients undergoing glaucoma surgery, Robert D. Fechtner, MD, reported at the Glaucoma 2006 meeting here.

Gold micro-shunt shows promise for lowering IOP

September 01, 2006

New York-A gold micro-shunt (GMS, SOLX) implant holds promise for reducing complications of trabeculectomy by lowering IOP, said Celso Tello, MD.